William Huffnagle
Chief Executive Officer at CDx Medical Holdings, Inc.
Profile
William J Huffnagle is currently the Chief Executive Officer & Director at CDx Medical Holdings, Inc. He was previously the Chief Executive Officer at CDx Diagnostics, Inc. and held the position of President-Reconstructive at Stryker Corp.
from 1998 to 2017.
William Huffnagle active positions
Companies | Position | Start |
---|---|---|
CDx Medical Holdings, Inc.
CDx Medical Holdings, Inc. Medical/Nursing ServicesHealth Services CDx Medical Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Suffern, NY. | Chief Executive Officer | - |
Former positions of William Huffnagle
Companies | Position | End |
---|---|---|
STRYKER CORPORATION | Corporate Officer/Principal | 2016-12-31 |
CDx Diagnostics, Inc.
CDx Diagnostics, Inc. Medical SpecialtiesHealth Technology CDx Diagnostics, Inc. develops and delivers instruments for detection and prevention of cancers. It is a specialized pathology lab that utilizes patented CDx Technology to analyze a disaggregated tissue specimen of the entire thickness of the suspect epithelium. The firm involves in detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx. CDx Diagnostics provides clinicians with unique tools to enhance their detection of precancerous change through complete epithelial sampling combined with computer-assisted morphological and molecular laboratory analysis. The company was founded by Mark Rutenberg and Drore Eisen in 1997 and is headquarters in Suffern, NY. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
STRYKER CORPORATION | Health Technology |
Private companies | 2 |
---|---|
CDx Diagnostics, Inc.
CDx Diagnostics, Inc. Medical SpecialtiesHealth Technology CDx Diagnostics, Inc. develops and delivers instruments for detection and prevention of cancers. It is a specialized pathology lab that utilizes patented CDx Technology to analyze a disaggregated tissue specimen of the entire thickness of the suspect epithelium. The firm involves in detection and prevention of cancers of the esophagus, oral cavity, pharynx, and larynx. CDx Diagnostics provides clinicians with unique tools to enhance their detection of precancerous change through complete epithelial sampling combined with computer-assisted morphological and molecular laboratory analysis. The company was founded by Mark Rutenberg and Drore Eisen in 1997 and is headquarters in Suffern, NY. | Health Technology |
CDx Medical Holdings, Inc.
CDx Medical Holdings, Inc. Medical/Nursing ServicesHealth Services CDx Medical Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Suffern, NY. | Health Services |
- Stock Market
- Insiders
- William Huffnagle